Aug 12 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2022 Jun 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.79 3.03 14.10
(-8.0 pct) (+9.2 pct)
Operating loss 212 mln loss 387 mln 160 mln
Recurring loss 212 mln loss 387 mln 190 mln
Net loss 140 mln loss 275 mln 130 mln
EPS loss 37.21 yen loss 72.97 yen 34.38 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T